---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-007288"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2026-02-18T23:59:59+00:00"
generated_at: "2026-05-16T02:02:20.907421+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Lipocine updates corporate presentation; no material new details disclosed

## Summary
- Filed an updated corporate presentation under Item 8.01.
- No specific financial or operational changes provided in the filing.
- The presentation is used for meetings with investors and analysts.
- No material events, guidance, or data points were disclosed.

## SEC filing metadata
- accession: 0001493152-26-007288
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2026-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315226007288/0001493152-26-007288-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315226007288/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-007288
- JSON: https://secwatch.observer/filing/0001493152-26-007288.json
- Plain text: https://secwatch.observer/filing/0001493152-26-007288.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.